JOHNSON CONTROLS INTERNATION (JCI)

IE00BY7QL619 - Common Stock

79.3  +0.64 (+0.81%)

After market: 79.3 0 (0%)

Fundamental Rating

3

Taking everything into account, JCI scores 3 out of 10 in our fundamental rating. JCI was compared to 40 industry peers in the Building Products industry. JCI has a medium profitability rating, but doesn't score so well on its financial health evaluation. JCI is valued expensive and it does not seem to be growing.



4

1. Profitability

1.1 Basic Checks

In the past year JCI was profitable.
In the past year JCI had a positive cash flow from operations.
JCI had positive earnings in each of the past 5 years.
In the past 5 years JCI always reported a positive cash flow from operatings.

1.2 Ratios

With a Return On Assets value of 3.99%, JCI is not doing good in the industry: 70.00% of the companies in the same industry are doing better.
JCI has a Return On Equity of 10.59%. This is in the lower half of the industry: JCI underperforms 60.00% of its industry peers.
The Return On Invested Capital of JCI (6.02%) is worse than 70.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for JCI is significantly below the industry average of 13.34%.
Industry RankSector Rank
ROA 3.99%
ROE 10.59%
ROIC 6.02%
ROA(3y)4%
ROA(5y)3.49%
ROE(3y)10.39%
ROE(5y)8.82%
ROIC(3y)6.34%
ROIC(5y)6%

1.3 Margins

JCI has a Profit Margin of 7.43%. This is comparable to the rest of the industry: JCI outperforms 45.00% of its industry peers.
JCI's Profit Margin has declined in the last couple of years.
JCI's Operating Margin of 10.53% is on the low side compared to the rest of the industry. JCI is outperformed by 62.50% of its industry peers.
JCI's Operating Margin has improved in the last couple of years.
JCI has a Gross Margin of 35.19%. This is comparable to the rest of the industry: JCI outperforms 52.50% of its industry peers.
JCI's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 10.53%
PM (TTM) 7.43%
GM 35.19%
OM growth 3Y-3.83%
OM growth 5Y11.73%
PM growth 3Y2.41%
PM growth 5Y-20.69%
GM growth 3Y1.1%
GM growth 5Y1.86%

2

2. Health

2.1 Basic Checks

JCI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
JCI has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, JCI has less shares outstanding
JCI has a worse debt/assets ratio than last year.

2.2 Solvency

An Altman-Z score of 1.91 indicates that JCI is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 1.91, JCI is doing worse than 82.50% of the companies in the same industry.
The Debt to FCF ratio of JCI is 5.94, which is a neutral value as it means it would take JCI, 5.94 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 5.94, JCI is doing worse than 70.00% of the companies in the same industry.
A Debt/Equity ratio of 0.56 indicates that JCI is somewhat dependend on debt financing.
The Debt to Equity ratio of JCI (0.56) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF 5.94
Altman-Z 1.91
ROIC/WACC0.89
WACC6.77%

2.3 Liquidity

JCI has a Current Ratio of 0.94. This is a bad value and indicates that JCI is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.94, JCI is doing worse than 92.50% of the companies in the same industry.
A Quick Ratio of 0.79 indicates that JCI may have some problems paying its short term obligations.
The Quick ratio of JCI (0.79) is worse than 87.50% of its industry peers.
Industry RankSector Rank
Current Ratio 0.94
Quick Ratio 0.79

3

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 6.00% over the past year.
The Earnings Per Share has been growing by 13.04% on average over the past years. This is quite good.
JCI shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -14.34%.
JCI shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.86% yearly.
EPS 1Y (TTM)6%
EPS 3Y11.73%
EPS 5Y13.04%
EPS Q2Q%21.9%
Revenue 1Y (TTM)-14.34%
Revenue growth 3Y-1.02%
Revenue growth 5Y-0.86%
Sales Q2Q%-9.49%

3.2 Future

The Earnings Per Share is expected to grow by 9.68% on average over the next years. This is quite good.
The Revenue is expected to grow by 3.16% on average over the next years.
EPS Next Y-3.3%
EPS Next 2Y5.82%
EPS Next 3Y9.69%
EPS Next 5Y9.68%
Revenue Next Year-10.72%
Revenue Next 2Y-3.76%
Revenue Next 3Y-0.73%
Revenue Next 5Y3.16%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

1

4. Valuation

4.1 Price/Earnings Ratio

JCI is valuated rather expensively with a Price/Earnings ratio of 21.37.
JCI's Price/Earnings ratio is in line with the industry average.
When comparing the Price/Earnings ratio of JCI to the average of the S&P500 Index (26.91), we can say JCI is valued slightly cheaper.
JCI is valuated rather expensively with a Price/Forward Earnings ratio of 22.10.
Based on the Price/Forward Earnings ratio, JCI is valued a bit more expensive than 62.50% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of JCI to the average of the S&P500 Index (23.26), we can say JCI is valued inline with the index average.
Industry RankSector Rank
PE 21.37
Fwd PE 22.1

4.2 Price Multiples

JCI's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. JCI is more expensive than 67.50% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of JCI indicates a slightly more expensive valuation: JCI is more expensive than 65.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 32.86
EV/EBITDA 18.57

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)1.64
EPS Next 2Y5.82%
EPS Next 3Y9.69%

6

5. Dividend

5.1 Amount

JCI has a Yearly Dividend Yield of 1.85%.
Compared to an average industry Dividend Yield of 1.10, JCI pays a better dividend. On top of this JCI pays more dividend than 95.00% of the companies listed in the same industry.
Compared to the average S&P500 Dividend Yield of 2.34, JCI is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.85%

5.2 History

The dividend of JCI is nicely growing with an annual growth rate of 6.63%!
JCI has been paying a dividend for at least 10 years, so it has a reliable track record.
JCI has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)6.63%
Div Incr Years3
Div Non Decr Years6

5.3 Sustainability

JCI pays out 58.65% of its income as dividend. This is a bit on the high side, but may be sustainable.
JCI's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP58.65%
EPS Next 2Y5.82%
EPS Next 3Y9.69%

JOHNSON CONTROLS INTERNATION

NYSE:JCI (1/13/2025, 4:02:44 PM)

After market: 79.3 0 (0%)

79.3

+0.64 (+0.81%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)11-06 2024-11-06/bmo
Earnings (Next)01-31 2025-01-31/bmo
Inst Owners94.25%
Inst Owner Change-0.02%
Ins Owners0.34%
Ins Owner Change2.29%
Market Cap52.51B
Analysts76.43
Price Target90.28 (13.85%)
Short Float %1.37%
Short Ratio2.53
Dividend
Industry RankSector Rank
Dividend Yield 1.85%
Dividend Growth(5Y)6.63%
DP58.65%
Div Incr Years3
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)4.92%
Min EPS beat(2)4.26%
Max EPS beat(2)5.59%
EPS beat(4)3
Avg EPS beat(4)2.87%
Min EPS beat(4)-0.74%
Max EPS beat(4)5.59%
EPS beat(8)4
Avg EPS beat(8)0.8%
EPS beat(12)5
Avg EPS beat(12)0.36%
EPS beat(16)7
Avg EPS beat(16)0.84%
Revenue beat(2)0
Avg Revenue beat(2)-8.07%
Min Revenue beat(2)-13.77%
Max Revenue beat(2)-2.38%
Revenue beat(4)0
Avg Revenue beat(4)-4.7%
Min Revenue beat(4)-13.77%
Max Revenue beat(4)-1.19%
Revenue beat(8)1
Avg Revenue beat(8)-3.31%
Revenue beat(12)2
Avg Revenue beat(12)-2.73%
Revenue beat(16)4
Avg Revenue beat(16)-2.13%
PT rev (1m)1.21%
PT rev (3m)15.57%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-9.77%
EPS NY rev (1m)-0.15%
EPS NY rev (3m)-9.9%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-16.99%
Revenue NY rev (1m)-0.13%
Revenue NY rev (3m)-11.33%
Valuation
Industry RankSector Rank
PE 21.37
Fwd PE 22.1
P/S 2.29
P/FCF 32.86
P/OCF 25.1
P/B 3.26
P/tB N/A
EV/EBITDA 18.57
EPS(TTM)3.71
EY4.68%
EPS(NY)3.59
Fwd EY4.52%
FCF(TTM)2.41
FCFY3.04%
OCF(TTM)3.16
OCFY3.98%
SpS34.66
BVpS24.31
TBVpS-7.18
PEG (NY)N/A
PEG (5Y)1.64
Profitability
Industry RankSector Rank
ROA 3.99%
ROE 10.59%
ROCE 7.86%
ROIC 6.02%
ROICexc 6.14%
ROICexgc 18.65%
OM 10.53%
PM (TTM) 7.43%
GM 35.19%
FCFM 6.96%
ROA(3y)4%
ROA(5y)3.49%
ROE(3y)10.39%
ROE(5y)8.82%
ROIC(3y)6.34%
ROIC(5y)6%
ROICexc(3y)6.58%
ROICexc(5y)6.25%
ROICexgc(3y)23.86%
ROICexgc(5y)23.9%
ROCE(3y)8.19%
ROCE(5y)7.69%
ROICexcg growth 3Y-13.87%
ROICexcg growth 5Y1.5%
ROICexc growth 3Y-4.43%
ROICexc growth 5Y10.29%
OM growth 3Y-3.83%
OM growth 5Y11.73%
PM growth 3Y2.41%
PM growth 5Y-20.69%
GM growth 3Y1.1%
GM growth 5Y1.86%
F-Score5
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF 5.94
Debt/EBITDA 2.77
Cap/Depr 60.54%
Cap/Sales 2.15%
Interest Coverage 250
Cash Conversion 64.73%
Profit Quality 93.72%
Current Ratio 0.94
Quick Ratio 0.79
Altman-Z 1.91
F-Score5
WACC6.77%
ROIC/WACC0.89
Cap/Depr(3y)65.14%
Cap/Depr(5y)62.93%
Cap/Sales(3y)2.17%
Cap/Sales(5y)2.16%
Profit Quality(3y)91.89%
Profit Quality(5y)135.07%
High Growth Momentum
Growth
EPS 1Y (TTM)6%
EPS 3Y11.73%
EPS 5Y13.04%
EPS Q2Q%21.9%
EPS Next Y-3.3%
EPS Next 2Y5.82%
EPS Next 3Y9.69%
EPS Next 5Y9.68%
Revenue 1Y (TTM)-14.34%
Revenue growth 3Y-1.02%
Revenue growth 5Y-0.86%
Sales Q2Q%-9.49%
Revenue Next Year-10.72%
Revenue Next 2Y-3.76%
Revenue Next 3Y-0.73%
Revenue Next 5Y3.16%
EBIT growth 1Y-13.4%
EBIT growth 3Y-4.81%
EBIT growth 5Y10.77%
EBIT Next Year12.4%
EBIT Next 3Y11.16%
EBIT Next 5Y8.77%
FCF growth 1Y-4.99%
FCF growth 3Y-6.18%
FCF growth 5Y20.42%
OCF growth 1Y-5.81%
OCF growth 3Y-5.6%
OCF growth 5Y11.44%